|Articles|May 1, 2002

May 2002
Volume 8
Issue 5

Current Indications for ACE Inhibitors and HOPE for the Future

Author(s)Stephanie Burch, PharmD, Narith Ou, PharmD

Download PDF: Current Indications for ACE Inhibitors and HOPE for the Future

Articles in this issue

about 24 years ago

Article

Is Quality Free? The Relationship Between Cost and Quality Across 18 Provider Groups

about 24 years ago

Article

Bridging the Electronic Divide: Patient and Provider Perspectives on E-mail Communication in Primary Care

about 24 years ago

Article

How Acceptable Are Financial Incentives and Written Feedback for Improving Hypertension Control? Perspectives from Physicians, Clinic Administrators, and Patients

about 24 years ago

Article

Identifying Cost Management Strategies in Dialysis Clinics: Sustainable Savings With Positive Outcomes

about 24 years ago

Article

The SF-36 General Health Status Survey Documents the Burden of Osteoarthritis and the Benefits of Total Joint Arthroplasty: But Why Should We Use It?

about 24 years ago

Article

Is Quality Free? It Depends

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Current Indications for ACE Inhibitors and HOPE for the Future

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology

Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD

Ontada Analysis Finds GLP-1 RA Use Linked to Improved Survival in Patients With Cancer

Orexin Agonist Shows Promise for Treating Narcolepsy, Hypersomnia: Richard Bogan, MD

FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs